We are working with cardiac technology innovators, research teams, healthcare professionals and patients to deliver better cardiovascular solutions & devices, user experiences and health outcomes.
Mechanical Circulatory Support
With heart disease on the increase, demand for cardiac assist devices is growing. We assist in the development of specific cardiovascular devices including Mechanical Circulatory Support (MCS), Ventricular Assist Devices (VADs) and Total Artificial Hearts (TAHs).
Our 10 year track record of MCS system development, including safety critical software and electronics, and transitioning from proof-of-principle to First-In-Human (FIH) trials is enabling our clients to develop better MCS solutions for patients and patient experience with human factors engineering investigation.
Demand for monitoring and alerting technologies in the form of implantable and external cardiac devices for physician and patient alerting is increasing.
Hydrix’s combined offering of engineering development services for Class III medical devices and regulatory guidance and strategy is helping bring these novel technologies to market. Recent development work includes technology integration for an implantable cardiac device and human factors engineering to develop novel concepts for cardiac Holter monitors.
A novel platform technology accelerating LVAD/TAH development
Hydrix has created a first of kind Mechanical Circulatory Support ‘platform technology’. Developed for emerging MCS innovators, it allows them more rapidly and accurately control their pump, enabling them to de-risk and accelerate their MCS device development program.
Hydrix has an established track record in the development of Mechanical Circulatory Support (MCS) technologies, specifically control systems and power management solutions for Left Ventricular Assist Devices (LVAD) and Total Artificial Hearts (TAH). With control system development also comes the human element. Whether the device is a bridge-to-transplant or destination-therapy, you are developing a complex system that must be worn and managed by people that are often elderly, very frail and unwell or otherwise incapacitated, while affording them an improved quality of life.
We have worked on a variety of projects exploring and brainstorming options for improved usability, for both adult and paediatric scenarios. Projects have encompassed usability trials through to market insights, including recent interviews with VAD coordinators, who liaise with the patient from evaluation and initial implant onwards, and who have an inherent understanding of the real-world struggles faced by patients.
"The Hydrix team's collaborative approach, controller development experience and innovation capabilities in user design were the best fit for Calon for our Ventricular Assist Device controller development."